Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HROW Relative to the S&P 500

HROW Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Harrow Inc. (NASD:HROW) seasonal charts above shows that a Buy Date of March 23 and a Sell Date of June 11 has resulted in a geometric average return of 15.73% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 31.48% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Harrow Inc is an?eyecare pharmaceutical company engaged in the discovery, development, and commercialization of?ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

To download HROW seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: HROW